Karas Eric sold SPRY
June 18, 2025 · Form 4 insider transaction
Karas Eric sold 15,000 shares of ARS Pharmaceuticals, Inc. at $16.00 per share, a transaction worth $240.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$16.00
Total value
$240.0K
InsiderKaras Eric
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 18, 2025
Filing dateJune 20, 2025
Shares owned after7,696
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024.